BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Federico A, Zulli C, de Sio I, Del Prete A, Dallio M, Masarone M, Loguercio C. Focus on emerging drugs for the treatment of patients with non-alcoholic fatty liver disease. World J Gastroenterol 2014; 20(45): 16841-16857 [PMID: 25492998 DOI: 10.3748/wjg.v20.i45.16841]
URL: https://www.wjgnet.com/1007-9327/full/v20/i45/16841.htm
Number Citing Articles
Wenya Meng, Zitong Zhao, Lingli Chen, Suyun Lin, Yang Zhang, Jing He, Kehui Ouyang, Wenjun Wang. Total Flavonoids from Chimonanthus nitens Oliv. Leaves Ameliorate HFD-Induced NAFLD by Regulating the Gut–Liver Axis in MiceFoods 2022; 11(14): 2169 doi: 10.3390/foods11142169
Rebekka Pohl, Lisa Rein-Fischboeck, Elisabeth M. Meier, Kristina Eisinger, Sabrina Krautbauer, Christa Buechler. Resolvin E1 and chemerin C15 peptide do not improve rodent non-alcoholic steatohepatitisExperimental and Molecular Pathology 2015; 98(2): 295 doi: 10.1016/j.yexmp.2015.02.005
Marta Gonzalez Rozas, Lidia Hernanz Roman, Diego Gonzalez Gonzalez, José Luis Pérez-Castrillón. Panhypopituitarism due to Absence of the Pituitary Stalk: A Rare Aetiology of Liver CirrhosisCase Reports in Endocrinology 2016; 2016: 1 doi: 10.1155/2016/9071097
Tomasz Kostrzewski, Terri Cornforth, Sophie A Snow, Larissa Ouro-Gnao, Cliff Rowe, Emma M Large, David J Hughes. Three-dimensional perfused human <i>in vitro</i> model of non-alcoholic fatty liver diseaseWorld Journal of Gastroenterology 2017; 23(2): 204-215 doi: 10.3748/wjg.v23.i2.204
Rohit Anthony Sinha, Paul M. Yen. Thyroid hormone-mediated autophagy and mitochondrial turnover in NAFLDCell & Bioscience 2016; 6(1) doi: 10.1186/s13578-016-0113-7
Eunsook S. Jin, A. Dean Sherry, Craig R. Malloy. An Oral Load of [13C3]Glycerol and Blood NMR Analysis Detect Fatty Acid Esterification, Pentose Phosphate Pathway, and Glycerol Metabolism through the Tricarboxylic Acid Cycle in Human LiverJournal of Biological Chemistry 2016; 291(36): 19031 doi: 10.1074/jbc.M116.742262
Luigi Marino, Adam Kim, Bin Ni, Francesco S. Celi. Thyroid hormone action and liver disease, a complex interplayHepatology 2023;  doi: 10.1097/HEP.0000000000000551
Weslie Y. Khoo, Benjamin J. Chrisfield, Sudathip Sae-tan, Joshua D. Lambert. Mitigation of nonalcoholic fatty liver disease in high-fat-fed mice by the combination of decaffeinated green tea extract and voluntary exerciseThe Journal of Nutritional Biochemistry 2020; 76: 108262 doi: 10.1016/j.jnutbio.2019.108262
Jin-ming Zhang, Xing-he Wang, Li-hong Hao, He Wang, Xiu-ying Zhang, Ishfaq Muhammad, Yue Qi, Guang-liang Li, Xiao-qi Sun. Nrf2 is crucial for the down-regulation of Cyp7a1 induced by arachidonic acid in Hepg2 cellsEnvironmental Toxicology and Pharmacology 2017; 52: 21 doi: 10.1016/j.etap.2017.03.003
Tisha R Joy, Charles A McKenzie, Rommel G Tirona, Kelly Summers, Shannon Seney, Subrata Chakrabarti, Neel Malhotra, Melanie D Beaton. Sitagliptin in patients with non-alcoholic steatohepatitis: A randomized, placebo-controlled trialWorld Journal of Gastroenterology 2017; 23(1): 141-150 doi: 10.3748/wjg.v23.i1.141
Xianghui Huang, Jia Xu, Yingxin Hu, Kunlun Huang, Yunbo Luo, Xiaoyun He. Broccoli ameliorate NAFLD by increasing lipolysis and promoting liver macrophages polarize toward M2-typeJournal of Functional Foods 2022; 89: 104898 doi: 10.1016/j.jff.2021.104898
Pegah Golabi, Cameron T Locklear, Patrick Austin, Sophie Afdhal, Melinda Byrns, Lynn Gerber, Zobair M Younossi. Effectiveness of exercise in hepatic fat mobilization in non-alcoholic fatty liver disease: Systematic reviewWorld Journal of Gastroenterology 2016; 22(27): 6318-6327 doi: 10.3748/wjg.v22.i27.6318
Lihua Song, Xin Gang Zhao, Peng Ling Ouyang, Qi Guan, Li Yang, Fengju Peng, Huanwang Du, Fei Yin, Wei Yan, Wen Juan Yu, Hongli Yan. Combined effect of n-3 fatty acids and phytosterol esters on alleviating hepatic steatosis in non-alcoholic fatty liver disease subjects: a double-blind placebo-controlled clinical trialBritish Journal of Nutrition 2020; 123(10): 1148 doi: 10.1017/S0007114520000495
Sha Li, Ning Wang, Yi-Gang Feng, Hong-Yun Li, Yibin Feng. Nutritional Antioxidant Therapies: Treatments and Perspectives2017; : 467 doi: 10.1007/978-3-319-67625-8_18
Abdelalim A. Gadallah, Abdullah R. Almasari. The effects of a high-fat diet on the liver of pregnant albino rats and their developing offspringEgyptian Journal of Basic and Applied Sciences 2023; 10(1): 567 doi: 10.1080/2314808X.2023.2245618
Mohammed Sharif Swallah, Hongliang Fan, Sainan Wang, Hansong Yu, Chunhong Piao. Prebiotic Impacts of Soybean Residue (Okara) on Eubiosis/Dysbiosis Condition of the Gut and the Possible Effects on Liver and Kidney FunctionsMolecules 2021; 26(2): 326 doi: 10.3390/molecules26020326
Elizabeth C Verna. Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in patients with HIVThe Lancet Gastroenterology & Hepatology 2017; 2(3): 211 doi: 10.1016/S2468-1253(16)30120-0
H. Jin, X. Xu, B. Pang, R. Yang, H. Sun, C. Jiang, D. Shao, J. Shi. Probiotic and prebiotic interventions for non-alcoholic fatty liver disease: a systematic review and network meta-analysisBeneficial Microbes 2021; 12(6): 517 doi: 10.3920/BM2020.0183
Neel Malhotra, Melanie D Beaton. Management of non-alcoholic fatty liver disease in 2015World Journal of Hepatology 2015; 7(30): 2962-2967 doi: 10.4254/wjh.v7.i30.2962
Sebastião Mauro Bezerra DUARTE, José Tadeu STEFANO, Denise Siqueira VANNI, Flair José CARRILHO, Claudia Pinto Marques Souza de OLIVEIRA. IMPACT OF CURRENT DIET AT THE RISK OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)Arquivos de Gastroenterologia 2019; 56(4): 431 doi: 10.1590/s0004-2803.201900000-67
Amrita Kandel, Poonam Pant, Sushila Todi, Sudhamshu KC, Sudip Pandey. Effect of exercise and pharmacotherapy on non-alcoholic fatty liver diseaseSAGE Open Medicine 2024; 12 doi: 10.1177/20503121241227090
Merilin Al Sharif, Petko Alov, Vessela Vitcheva, Antonia Diukendjieva, Mattia Mori, Bruno Botta, Ivanka Tsakovska, Ilza Pajeva. Natural modulators of nonalcoholic fatty liver disease: Mode of action analysis and in silico ADME-Tox predictionToxicology and Applied Pharmacology 2017; 337: 45 doi: 10.1016/j.taap.2017.10.013
Jeļizaveta Sokolovska, Sergejs Isajevs, Evita Rostoka, Tatjana Sjakste, Ilva Trapiņa, Kristīne Ošiņa, Natalia Paramonova, Nikolajs Sjakste. Changes in glucose transporter expression and nitric oxide production are associated with liver injury in diabetesCell Biochemistry and Function 2015; 33(6): 366 doi: 10.1002/cbf.3123
Kandy T Velázquez, Reilly T Enos, Jackie E Bader, Alexander T Sougiannis, Meredith S Carson, Ioulia Chatzistamou, James A Carson, Prakash S Nagarkatti, Mitzi Nagarkatti, E Angela Murphy. Prolonged high-fat-diet feeding promotes non-alcoholic fatty liver disease and alters gut microbiota in miceWorld Journal of Hepatology 2019; 11(8): 619-637 doi: 10.4254/wjh.v11.i8.619
E. Roeb, A. Canbay. Nichtalkoholische FettlebererkrankungenDer Gastroenterologe 2016; 11(3): 205 doi: 10.1007/s11377-016-0063-y
Meng‐Meng You, Yi‐Chen Liu, Yi‐Fan Chen, Yong‐Ming Pan, Zhuo‐Ning Miao, Yi‐Zhen Shi, Juan‐Juan Si, Min‐Li Chen, Fu‐Liang Hu. Royal jelly attenuates nonalcoholic fatty liver disease by inhibiting oxidative stress and regulating the expression of circadian genes in ovariectomized ratsJournal of Food Biochemistry 2020; 44(3) doi: 10.1111/jfbc.13138
Mohamed Tausif Siddiqui, Hina Amin, Rajat Garg, Pravallika Chadalavada, Wael Al-Yaman, Rocio Lopez, Amandeep Singh. Medications in type-2 diabetics and their association with liver fibrosisWorld Journal of Gastroenterology 2020; 26(23): 3249-3259 doi: 10.3748/wjg.v26.i23.3249
Yongqing Zhou, Ping Li, Xin Wang, Chuanchen Wu, Nannan Fan, Xiaoning Liu, Lijie Wu, Wei Zhang, Wen Zhang, Zhenzhen Liu, Bo Tang. In situvisualization of peroxisomal viscosity in the liver of mice with non-alcoholic fatty liver disease by near-infrared fluorescence and photoacoustic imagingChemical Science 2020; 11(44): 12149 doi: 10.1039/D0SC02922J
Hyunjin Park, Yanan Liu, Hyun-Sook Kim, Jung-Hee Shin. Chokeberry attenuates the expression of genes related to de novo lipogenesis in the hepatocytes of mice with nonalcoholic fatty liver diseaseNutrition Research 2016; 36(1): 57 doi: 10.1016/j.nutres.2015.10.010
Adriano Lama, Claudio Pirozzi, Maria Pia Mollica, Giovanna Trinchese, Francesca Di Guida, Gina Cavaliere, Antonio Calignano, Giuseppina Mattace Raso, Roberto Berni Canani, Rosaria Meli. Polyphenol‐rich virgin olive oil reduces insulin resistance and liver inflammation and improves mitochondrial dysfunction in high‐fat diet fed ratsMolecular Nutrition & Food Research 2017; 61(3) doi: 10.1002/mnfr.201600418
Alessandro Federico, Marcello Dallio, Antonietta Gerarda Gravina, Nadia Diano, Sonia Errico, Mario Masarone, Mario Romeo, Concetta Tuccillo, Paola Stiuso, Filomena Morisco, Marcello Persico, Carmelina Loguercio. The Bisphenol A Induced Oxidative Stress in Non-Alcoholic Fatty Liver Disease Male Patients: A Clinical Strategy to Antagonize the Progression of the DiseaseInternational Journal of Environmental Research and Public Health 2020; 17(10): 3369 doi: 10.3390/ijerph17103369
Pratima Dibba, Andrew Li, Brandon Perumpail, Nimy John, Sandy Sallam, Neha Shah, Waiyee Kwong, George Cholankeril, Donghee Kim, Aijaz Ahmed. Emerging Therapeutic Targets and Experimental Drugs for the Treatment of NAFLDDiseases 2018; 6(3): 83 doi: 10.3390/diseases6030083
Bingjian Wen, Chengcheng Zhang, Jingwen Zhou, Zhengyan Zhang, Qishi Che, Hua Cao, Yan Bai, Jiao Guo, Zhengquan Su. Targeted treatment of alcoholic liver disease based on inflammatory signalling pathwaysPharmacology & Therapeutics 2021; 222: 107752 doi: 10.1016/j.pharmthera.2020.107752
Wei Jiang, Mei-Hua Guo, Xin Hai. Hepatoprotective and antioxidant effects of lycopene on non-alcoholic fatty liver disease in ratWorld Journal of Gastroenterology 2016; 22(46): 10180-10188 doi: 10.3748/wjg.v22.i46.10180